Related Experiment Video
Updated: Jul 26, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Waitlist and Transplant Outcomes in Organ Donation After Circulatory Death: Trends in the United States
Jennie H Kwon1, Walker M Blanding1, Khaled Shorbaji1
1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC.
Insights
Organ donation after circulatory death (DCD) improves transplant access and waitlist outcomes for liver and heart patients. While DCD kidney, liver, and lung transplants show increased mortality, survival remains acceptable.
Area of Science:
- Transplantation Medicine
- Organ Donation
- Public Health
Background:
- Organ donation after circulatory death (DCD) has expanded the donor pool for solid organ transplantation.
- DCD is increasingly utilized, particularly in heart transplantation.
Purpose of the Study:
- To evaluate waitlist and transplant outcomes for kidney, liver, lung, and heart transplantation using DCD.
- Compare outcomes between DCD and donation after brain death (DBD) for various organs.
Main Methods:
- Utilized the United Network for Organ Sharing registry for adult transplant candidates and recipients.
- Employed propensity matching and competing-risks regression for waitlist outcomes.
- Applied propensity matching, Kaplan-Meier, and Cox regression for survival analysis.
Main Results:
- DCD transplant volumes have significantly increased across all organs.
- Liver candidates for DCD organs had higher transplant rates; heart and liver candidates had reduced waitlist deterioration.
- DCD kidney, liver, and lung recipients showed increased mortality risk up to 5 years post-transplant compared to DBD, with no difference in 1-year heart transplant mortality.
Conclusions:
- DCD expands transplantation access and improves waitlist outcomes for liver and heart candidates.
- Despite increased mortality risks in DCD kidney, liver, and lung transplantation, overall survival is considered acceptable.
- DCD is a valuable strategy for increasing organ availability and improving patient outcomes in transplantation.
Objectives:
To summarize waitlist and transplant outcomes in kidney, liver, lung, and heart transplantation using organ donation after circulatory death (DCD).
Background:
DCD has expanded the donor pool for solid organ transplantation, most recently for heart transplantation.
Methods:
The United Network for Organ Sharing registry was used to identify adult transplant candidates and recipients in the most recent allocation policy eras for kidney, liver, lung, and heart transplantation. Transplant candidates and recipients were grouped by acceptance criteria for DCD versus brain-dead donors [donation after brain death (DBD)] only and DCD versus DBD transplant, respectively. Propensity matching and competing-risks regression was used to model waitlist outcomes. Survival was modeled using propensity matching and Kaplan-Meier and Cox regression analysis.
Results:
DCD transplant volumes have increased significantly across all organs. Liver candidates listed for DCD organs were more likely to undergo transplantation compared with propensity-matched candidates listed for DBD only, and heart and liver transplant candidates listed for DCD were less likely to experience death or clinical deterioration requiring waitlist inactivation. Propensity-matched DCD recipients demonstrated an increased mortality risk up to 5 years after liver and kidney transplantation and up to 3 years after lung transplantation compared with DBD. There was no difference in 1-year mortality between DCD and DBD heart transplantation.
Conclusions:
DCD continues to expand access to transplantation and improves waitlist outcomes for liver and heart transplant candidates. Despite an increased risk for mortality with DCD kidney, liver, and lung transplantation, survival with DCD transplant remains acceptable.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management

